In a second group of experiments using
human tissue from patients with
pancreatic ductal adenocarcinoma, which accounts for more than 90 percent of
pancreatic cancers, Zheng and his colleagues also tracked down a link between the abundance of Sema3D in those
tissues and the progression of metastatic
pancreatic cancer.